PCA
AGN

Peddock Capital Advisors’s Allergan plc AGN Stock Holding History

Peddock Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,174
Closed -$385K – 106
2020
Q1 		$385K Hold
2,174
– – 0.29% 68
2019
Q4 		$416K Hold
2,174
– – 0.21% 78
2019
Q3 		$366K Sell
2,174
-564
-21% -$91.9K 0.2% 81
2019
Q2 		$458K Buy
2,738
+14
+0.5% +$1.94K 0.24% 77
2019
Q1 		$399K Buy
2,724
+326
+14% +$47.3K 0.22% 76
2018
Q4 		$320K Sell
2,398
-1,999
-45% -$328K 0.19% 79
2018
Q3 		$837K Sell
4,397
-82
-2% -$15.1K 0.4% 53
2018
Q2 		$747K Sell
4,479
-336
-7% -$53.9K 0.37% 56
2018
Q1 		$810K Buy
4,815
+259
+6% +$43.4K 0.43% 53
2017
Q4 		$745K Sell
4,556
-2,645
-37% -$475K 0.37% 59
2017
Q3 		$1.48M Buy
7,201
+134
+2% +$31.2K 0.76% 22
2017
Q2 		$1.72M Buy
+7,067
New +$1.66M 0.91% 14

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Peddock Capital Advisors's AGN Position: Q2 2020 in Review

Peddock Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,174 shares — an estimated $385K sold.

Peddock Capital Advisors first reported a position in AGN in Q2 2017 and held it in 12 quarters. The position peaked at $1.72M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Peddock Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Peddock Capital Advisors sold 2,174 Allergan plc shares in Q2 2020, an estimated $385K.
  • Peddock Capital Advisors first reported a position in Allergan plc in Q2 2017 and held it in 12 quarters.
  • Peddock Capital Advisors's Allergan plc position peaked at $1.72M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Peddock Capital Advisors's 13F filing for Q2 2020, filed 11 Aug 2020.